Study of the effect of Metformin,OC pills versus their combination on thyroid and lipid profile in patients with Polycystic ovary syndrome
Not Applicable
- Conditions
- Health Condition 1: null- PCOD
- Registration Number
- CTRI/2017/09/009807
- Lead Sponsor
- self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All adult patients (18 to 40 years old) who are newly diagnosed with PCOS and have shown no symptomatic benefit after being prescribed lifestyle modification for 3 months.
2.Patients who are willing to give written informed consent.
3.Patients who have not previously diagnosed with a thyroid disorder.
Exclusion Criteria
1.Pregnant and lactating women.
2.Patients with other comorbid conditions
3.Patients who are taking other medications which could interfere with planned biochemical measurements.
4.Patients who have a history of treatment with study medications or any other androgen progestin or estrogen consumption, for any other indications in the past 6 months.
5.Patients who have known hypersensitivity to the study medications
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect of Metformin, Estrogen-progesterone pills versus their combination on thyroid and lipid profile in PCOS patients.Timepoint: 1,3MONTHS
- Secondary Outcome Measures
Name Time Method (1)Correlation between thyroid profile, lipid profile with age and BMI. <br/ ><br>(2)Comparison of the effect of Metformin, Estrogen-progesterone pills versus their combination on thyroid profile, lipid profile in PCOS patients. <br/ ><br>Timepoint: 1,3 MONTHS